Clarissa Uhlar
- Molecular Biology top 10%
- Oncology top 5%
- Hematology top 2%
- Immunology top 5%
- Surgery top 10%
- Co-authors
- Alexander S. WhiteheadPaul M. SharpSaad Z. UsmaniHuaibao FengNizar J. BahlisPeter M. VoorheesTahamtan AhmadiBrendan M. Weiss
- Topics
- Multiple Myeloma Research and Treatments (21 papers)Chronic Lymphocytic Leukemia Research (9 papers)Monoclonal and Polyclonal Antibodies Research (8 papers)
- Cited by
- HematologyImmunologyOncology
- Partner nations
- United StatesCanadaNetherlands
In The Last Decade
Clarissa Uhlar
33 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 104
- Molecular Biology 934
- Oncology 551
- Hematology 538
- Immunology 457
- Surgery 360
Countries citing papers authored by Clarissa Uhlar
This map shows the geographic impact of Clarissa Uhlar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clarissa Uhlar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clarissa Uhlar more than expected).
Fields of papers citing papers by Clarissa Uhlar
This network shows the impact of papers produced by Clarissa Uhlar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clarissa Uhlar. The network helps show where Clarissa Uhlar may publish in the future.
Co-authorship network of co-authors of Clarissa Uhlar
This figure shows the co-authorship network connecting the top 25 collaborators of Clarissa Uhlar. A scholar is included among the top collaborators of Clarissa Uhlar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clarissa Uhlar. Clarissa Uhlar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 28 | |
| 5 | 2 | |
| 6 | 26 | |
| 7 | 0 | |
| 8 | 74 | |
| 9 | 8 | |
| 10 | 26 | |
| 11 | Clinical efficacy of daratumumab monotherapy in patients with heavily pretreated relapsed or refractory multiple myelomabreakdown → | 303 |
| 12 | 11 | |
| 13 | 14 | |
| 14 | Serum amyloid A, the major vertebrate acute‐phase reactantbreakdown → | 867 |
| 15 | 151 | |
| 16 | 48 | |
| 17 | 8 | |
| 18 | 17 | |
| 19 | 126 | |
| 20 | 55 |
About Clarissa Uhlar
Clarissa Uhlar is a scholar working on Hematology, Genetics and Oncology, having authored 35 papers that have together received 1.9k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (21 papers), Chronic Lymphocytic Leukemia Research (9 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). The work is most often cited by research in Hematology (538 citations), Immunology (457 citations) and Oncology (551 citations). Clarissa Uhlar has collaborated with scholars based in United States, Canada and Netherlands. Frequent co-authors include Alexander S. Whitehead, Paul M. Sharp, Saad Z. Usmani, Huaibao Feng, Nizar J. Bahlis, Peter M. Voorhees, Tahamtan Ahmadi, Brendan M. Weiss, Sagar Lonial and Liselotte E. Jensen. Their work appears in journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.